Newsfeeds - Spark Newswire

2 minute read

Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher

Today, 12:00 PM

Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P also fell, dropping 0.26% to 4,379.88.

ADMS

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 12:00 PM

ADMS

1 minute read

Analyst Ratings

Where Protagonist Therapeutics Stands With Analysts

By Benzinga Insights

Today, 12:00 PM

Within the last quarter, Protagonist Therapeutics (NASDAQ:PTGX) has observed the following analyst ratings:

PTGX

2 minute read

Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals

By Lisa Levin

Today, 12:00 PM

Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also rose, gaining 0.44% to 4,410.73.

ADMS

2 minute read

28 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 12:00 PM

Gainers

ACY

1 minute read

Northland Capital Markets Upgrades Protagonist Therapeutics to Outperform, Announces $40 Price Target

By Benzinga Newsdesk

Today, 12:00 PM

Northland Capital Markets analyst Tim Chiang upgrades Protagonist Therapeutics (NASDAQ:PTGX) from Market Perform to Outperform and announces $40 price target.

PTGX

1 minute read

Protagonist Shares Almost Double As FDA Lifts Clinical Hold On Rusfertide Program

By Vandana Singh

Today, 12:00 PM

The FDA has removed the full clinical hold on Protagonist Therapeutics Inc’s (NASDAQ:PTGX) rusfertide clinical studies. The Company provided the requested individual…

PTGX

1 minute read

Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Monday, Oct. 11, 2021: SOFI, PTGX, GTLB, PRPH, AVDL

By Benzinga Newsdesk

Today, 12:00 PM

Today's 5 Stock Ideas: SoFi Technologies (SOFI) - Shares were up 4% following initiation of coverage by a Morgan Stanley analyst. The analyst set an Overweight rating (the equivalent of a buy) and a set a $25

AVDL

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 12:00 PM

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at $1.6 billion.

ADMS

2 minute read

FDA
News

Protagonist Therapeutics Announces Removal Of FDA Clinical Hold On The Rusfertide Clinical Development Program

By Benzinga Newsdesk

Today, 12:00 PM

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has removed the full clinical hold on the Company's

PTGX